PROCEPT BioRobotics Corp. (PRCT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about PROCEPT BioRobotics Corp. (PRCT)
Company Performance

Current Price

as of Oct 11, 2024

$71.70

P/E Ratio

N/A

Market Cap

$3.76B

Description

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Metrics

Overview

  • HQSan Jose, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerPRCT
  • Price$71.7-0.84%

Trading Information

  • Market Cap$3.76B
  • Float94.26%
  • Average Daily Volume (1m)655,283
  • Average Daily Volume (3m)705,491
  • EPS-$2.06

Company

  • Revenue$176.58M
  • Rev Growth (1yr)61.17%
  • Net Income-$25.63M
  • Gross Margin56.63%
  • EBITDA Margin-47.91%
  • EBITDA-$25.56M
  • EV$3.02B
  • EV/Revenue17.11
  • P/EN/A
  • P/S21.14
  • P/B14.91